Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Trends in Biotechnology and Pharmacy is Scopus-indexed (Q3, CiteScore 0.9). It is covered by India's One Nation One Subscription scheme for reading access. Published by Association of Biotechnology and Pharmacy.
Checked against the index lists dated .
ISSN 0973-8916Verify ISSN ↗2230-7303Verify ISSN ↗
Publisher: Association of Biotechnology and Pharmacy
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 143 / 191 | 25th | Q3 |
| Biotechnology | 282 / 325 | 13th | Q4 |
| Drug Discovery | 142 / 161 | 12th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q3, CiteScore 0.9.
Current Trends in Biotechnology and Pharmacy is Q3 in Pharmaceutical Science (rank 143 of 191), Q4 in Biotechnology (rank 282 of 325) and Q4 in Drug Discovery (rank 142 of 161), by CiteScore 2025.
Current Trends in Biotechnology and Pharmacy is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.9, quartile Q3, 25th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.168, quartile Q3, with an H-index of 19.
Current Trends in Biotechnology and Pharmacy is published by Association of Biotechnology and Pharmacy. Its print ISSN is 0973-8916 and its online ISSN is 2230-7303.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Trends in Biotechnology and Pharmacy has an h-index of 19 and a 2-year mean of 0.49 citations per paper (OpenAlex). Its Scopus CiteScore is 0.9, quartile Q3. On 2-year citations it ranks #134 of 177 Scopus journals in Pharmaceutical Science.
Current Trends in Biotechnology and Pharmacy published 101 papers in 2025; its busiest recent year was 2020 with 101. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 89 research articles (2025–2026), authors are most often from India (76.4%), Malaysia (8.4%) and Indonesia (3.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.